A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Saccharomyces boulardii in Infants and Children With Acute Diarrhea
Open accessAbstract
Aim: This study was designed to assess the efficacy and safety of Saccharomyces cerevisiae variant boulardii CNCM I-3799 ( S . boulardii CNCM I-3799) in the management of acute diarrhea in children. Methods: A total of 100 infants and children 3–36 months of age with acute diarrhea received medical care according to the World Health Organization guidelines on the management of acute diarrhea in children and were randomly allocated to the probiotic group ( S. boulardii CNCM I-3799 at a daily dose of 5 billion CFU twice daily) or to the placebo group. Infants and children were treated for 5 days and an extended follow-up was planned 1 and 2 months after the end of the treatment period. Primary endpoint was the time of recovery from diarrhea defined as the duration of diarrhea. Other parameters, such as frequency and consistency of stools, associated with the severity of diarrhea episodes were defined as secondary endpoints. Results: The administration of S. boulardii CNCM I-3799 was associated with beneficial effects on duration and severity of diarrhea. The time of recovery from diarrhea was significantly shorter in the probiotic group compared with the placebo group (65.8 ± 12 hours vs. 95.3 ± 17.6 hours, P = 0.0001). Faster remission in the probiotic group was also demonstrated by a shorter time before the first episode of semisolid stool [−23.5 hours, diff (95% CI): −7.99 (−31.49 to −15.51), P = 0.0001] and the faster normalization of stool consistency. S. boulardii CNCM I-3799 was well tolerated. Conclusion: S. boulardii CNCM I-3799 supplementation in children with acute diarrhea was shown effective in reducing the duration and severity of diarrhea in infants and children.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CNCM I-3799 (Ecoviva, Sporit GG) shortened pediatric acute diarrhea duration (65.8 vs. 95.3 hours, p = 0.0001) without adverse events.
“Similarly, CNCM I-3799 (Ecoviva, Sporit GG) shortened pediatric acute diarrhea duration (65.8 vs. 95.3 hours, p = 0.0001) without adverse events, highlighting its resilience and safety.45”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and <i>in vitro</i> assessment (2026) · cites this paper as [45]
The Results (Primary Endpoint and Secondary Endpoints; page unavailable) support the reported recovery times and P value for children receiving S. boulardii CNCM I-3799 versus placebo. But the Results (Safety Evaluation; page unavailable) report adverse events in 14.3% of probiotic recipients, although none were judged possibly linked to the product. The Methods (Interventions; page unavailable) name the test product as LesunBerry Sundyota Numandis, not Ecoviva or Sporit GG. (LLM, conf=0.92)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Liu, L., Oza, S., Hogan, D., Chu, Y., Perin, J., Zhu, J., Lawn, J. E., Cousens, S., Mathers, C., & Black, R. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31593-8 · Cited by 3,453 · see citing works
The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000.
Kosek, M. N., Bern, C., & Guerrant, R. L. (2003) · Europe PMC (PubMed Central) · Cited by 1,617 · see citing works
Guarino, A., Ashkenazi, S., Gendrel, D., Lo Vecchio, A., Shamir, R., & Szajewska, H. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000375 · Cited by 935 · see citing works
Probiotics for treating acute infectious diarrhoea
Allen, S. J., Martinez, E. G., Gregorio, G. V., & Dans, L. F. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003048.pub3 · Cited by 628 · see citing works
Canani, R. B., Cirillo, P., Terrin, G., Cesarano, L., Spagnuolo, M. I., Vincenzo, A. D., Albano, F., Passariello, A., Marco, G. D., Manguso, F., et al. (2007) · BMJ · doi:10.1136/bmj.39272.581736.55 · Cited by 328 · see citing works
Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis
Freedman, S. B., Williamson-Urquhart, S., Farion, K. J., Gouin, S., Willan, A. R., Poonai, N., Hurley, K. F., Sherman, P. M., Finkelstein, Y., Lee, B. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802597 · Cited by 239 · see citing works
<i>Lactobacillus rhamnosus</i> GG versus Placebo for Acute Gastroenteritis in Children
Schnadower, D., Tarr, P. I., Casper, T. C., Gorelick, M. H., Dean, J. M., O’Connell, K. J., Mahajan, P., Levine, A. C., Bhatt, S. R., Roskind, C. G., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802598 · Cited by 208 · see citing works
Probiotics for treating acute infectious diarrhoea
(2010) · Prescriber · doi:10.1002/psb.701 · Cited by 159 · see citing works
Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea
Billoo, A. G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i28.4557 · Cited by 136 · see citing works
Szajewska, H., Kołodziej, M., Gieruszczak‐Białek, D., Skórka, A., Ruszczyński, M., & Shamir, R. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15267 · Cited by 120 · see citing works
Czerucka, D., & Rampal, P. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i18.2188 · Cited by 116 · see citing works
Universal recommendations for the management of acute diarrhea in nonmalnourished children
Guarino, A., Lo Vecchio, A., Dias, J. A., Berkley, J. A., Boey, C., Bruzzese, D., Cohen, M. B., Cruchet, S., Liguoro, I., Salazar‐Lindo, E., et al. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000002053 · Cited by 108 · see citing works
Efficacy and Safety of Saccharomyces boulardii for Acute Diarrhea
Feizizadeh, S., Salehi‐Abargouei, A., & Akbari, V. (2014) · PEDIATRICS · doi:10.1542/peds.2013-3950 · Cited by 95 · see citing works
Influence of Saccharomyces boulardii CNCM I-745 on the gut-associated immune system
Stier, H., & Bischoff, S. C. (2016) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s111003 · Cited by 91 · see citing works
Florez, I. D., Veroniki, A.-A., Al Khalifah, R., Yepes-Nuñez, J. J., Sierra, J. M., Vernooij, R. W. M., Acosta-Reyes, J., Granados, C. M., Pérez-Gaxiola, G., Cuello-Garcia, C., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0207701 · Cited by 87 · see citing works
Szajewska, H., & Skórka, A. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04113.x · Cited by 66 · see citing works
Özkan, T., Sahin, E., Erdemır, G., & Budak, F. (2007) · Journal of International Medical Research · doi:10.1177/147323000703500204 · Cited by 49 · see citing works
Dinleyici, E. Ç., Kara, A., Dalgıç, N., Kurugöl, Z., Arıca, V., Akcan, Ö. M., Temur, E., Türel, Ö., Güven, Ş., Yasa, O., et al. (2015) · Beneficial Microbes · doi:10.3920/bm2014.0086 · Cited by 47 · see citing works
Das, S., Gupta, P. K., & Das, R. R. (2016) · Journal of Tropical Pediatrics · doi:10.1093/tropej/fmw032 · Cited by 45 · see citing works
Riaz, M., Alam, S., Malik, A., & Ali, S. M. (2012) · The Indian Journal of Pediatrics · doi:10.1007/s12098-011-0573-z · Cited by 43 · see citing works
Efficacy of probiotics in acute diarrhoea in children
Bhat, S., Shreekrishna, G. N., & Savio, C. (2018) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20182582 · Cited by 20 · see citing works
Asmat, S., Shaukat, F., Asmat, R., et al. (2018) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2018.03.214 · Cited by 16 · see citing works
Burande, M. A. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.114603 · Cited by 14 · see citing works
Salloju, V., Saireddy, S., Keerthi, T., & Kumari.Mantada, P. (2017) · Indonesian Journal of Clinical Pharmacy · doi:10.15416/ijcp.2017.6.2.91 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Huang, R., Xing, H.-Y., Liu, H.-J., Chen, Z.-F., & Tang, B.-B. (2021) · Translational Pediatrics · doi:10.21037/tp-21-511 · Cited by 48 · see citing works
Rondanelli, M., Miraglia, N., Putignano, P., Castagliuolo, I., Brun, P., Dall’Acqua, S., Peroni, G., Faliva, M. A., Naso, M., Nichetti, M., et al. (2021) · Nutrients · doi:10.3390/nu13082512 · Cited by 31 · see citing works
Madhumathi, I., Ramesh, V., Rathakrishnan, B., Abirami, B., Gunasekaran, K., Kumar, T. S., Jeyasankar, P., Raja, G., Selvam, K., Rajendran, S., et al. (2026) · Gut microbes reports · doi:10.1080/29933935.2026.2668863
- Authors
- Mourey, F., Sureja, V., Kheni, D., Shah, P., Parikh, D., Upadhyay, U., Satia, M., Shah, D., Troise, C., & Decherf, A.
- Affiliations
- Lesaffre (France) (FR)
- Sundyota Numandis Probioceuticals Pvt. Ltd.
- Hitarth Children Hospital
- Bakeri Medical Research Centre
- Iqra Hospital
- Ethicare Clinical Trial Services, Ahmedabad, India.
- Corresponding author
- Mourey, Florian
- Troise, Charlotte
- Decherf, Amélie
- Venue
- Pediatric Infectious Disease Journal
- Published
- 2020-08-14
- Volume
- 39
- Issue
- 11
- Pages
- e347-e351
- ISSN
- 0891-3668 (ISSN-L)
- PMC
- PMC7556239
- OpenAlex
- W3049478906
- Cited by
- 33
- References
- 24
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 8 · 2023: 5 · 2022: 5 · 2021: 5
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Pediatric Infectious Disease Journal (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Saccharomyces boulardii, probiotics, acute diarrhea, infants, children, diarrhea duration, stool consistency, probiotic safety, pediatric diarrhea treatment
- MeSH terms
- Saccharomyces boulardii, Acute Disease, Child, Preschool, Diarrhea, Double-Blind Method, Feces, Female, Humans, India, Infant, Male, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
